Elevated Chitin Content Reduces the Susceptibility of Candida Species to Caspofungin
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
The echinocandin antifungal drugs inhibit synthesis of the major fungal cell wall polysaccharide β(1,3)-glucan. Echinocandins have good efficacy against Candida albicans but reduced activity against other Candida species, in particular Candida parapsilosis and Candida guilliermondii . Treatment of Candida albicans with a sub-MIC level of caspofungin has been reported to cause a compensatory increase in chitin content and to select for sporadic echinocandin-resistant FKS1 point mutants that also have elevated cell wall chitin. Here we show that elevated chitin in response to caspofungin is a common response in various Candida species. Activation of chitin synthesis was observed in isolates of C. albicans , Candida tropicalis , C. parapsilosis , and C. guilliermondii and in some isolates of Candida krusei in response to caspofungin treatment. However, Candida glabrata isolates demonstrated no exposure-induced change in chitin content. Furthermore, isolates of C. albicans , C. krusei , C. parapsilosis , and C. guilliermondii which were stimulated to have higher chitin levels via activation of the calcineurin and protein kinase C (PKC) signaling pathways had reduced susceptibility to caspofungin. Isolates containing point mutations in the FKS1 gene generally had higher chitin levels and did not demonstrate a further compensatory increase in chitin content in response to caspofungin treatment. These results highlight the potential of increased chitin synthesis as a potential mechanism of tolerance to caspofungin for the major pathogenic Candida species.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Eventually, persistent echinocandin exposure leads to FKS mutations and organisms with marked and stable resistance emerge with a high chitin content in the cell wall (Walker et al., 2013; Perlin, 2015).”
From Fungal Cell Wall: Emerging Antifungals and Drug Resistance. (2019) · cites this paper as Walker et al., 2013
Experimental — accuracy not yet measuredIn the citing paper
“It is also reported in the literature that fungi develop resistance by increasing chitin levels when exposed to antimicrobial agents59.”
From Synergistic and antagonistic contributions of main components to the bioactivity profile of Anethum graveolens extract (2025) · cites this paper as [59]
In the citing paper
“In addition to genetic determinants of tolerance level, growth conditions influence the degree of tolerance exhibited by a strain.”
From Drug resistance and tolerance in fungi. (2020) · cites this paper as [76]
In the citing paper
“For example, conditions that increase cell wall chitin promote cell survival in the presence of echinocandin76,77, whereas calcineurin inhibitors reduce echinocandin tolerance (measured using MIC assays analyzed after 72 h)68,78.”
From Drug resistance and tolerance in fungi. (2020) · cites this paper as [76]
In the citing paper
“Induction of the CWI pathway in Candida species (Stevens et al., 2006; Walker et al., 2013), including C. glabrata (Cota et al., 2008), has been linked to increased production of other cell wall components, such as chitin, potentially compensating for the loss of beta-1,3-glucans.”
From Genetic Drivers of Multidrug Resistance in Candida glabrata (2016) · cites this paper as Walker et al., 2013
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174
Hoffman, C. S., & Winston, F. (1987) · Gene · doi:10.1016/0378-1119(87)90131-4 · Cited by 2,479
Espinel-Ingroff, A. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.10.2950-2956.1998 · Cited by 576
Resistance to echinocandin-class antifungal drugs.
Perlin, D. S. (2007) · Drug Resistance Updates · doi:10.1016/j.drup.2007.04.002 · Cited by 512 · cited 1×
“albicans occurs at Ser(645), in the first hot spot region (21, 22).”
BackgroundStimulation of Chitin Synthesis Rescues Candida albicans from Echinocandins
Walker, L. A., Munro, C. A., de Bruijn, I., Lenardon, M. D., McKinnon, A., & Gow, N. A. R. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000040 · Cited by 445 · cited 10×
“Often, this cell wall salvage mechanism results in increased chitin synthesis (7, 37, 39).”
BackgroundInfluentialSelf-citationPark, S., Kelly, R., Kahn, J. N., Robles, J., Hsu, M.-J., Register, E., Li, W., Vyas, V., Fan, H., Abruzzo, G., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3264-3273.2005 · Cited by 434
Ram, A. F. J., & Klis, F. M. (2006) · Nature Protocols · doi:10.1038/nprot.2006.397 · Cited by 418
Echinocandin Antifungal Drugs in Fungal Infections: A Comparison
Chen, S. C.-A., Slavin, M. A., & Sorrell, T. C. (2011) · Drugs · doi:10.2165/11585270-000000000-00000 · Cited by 371
Douglas, C. M., D'Ippolito, J. A., Shei, G. J., Meinz, M., Onishi, J., Marrinan, J. A., Li, W., Abruzzo, G. K., Flattery, A., Bartizal, K., et al. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.11.2471 · Cited by 344 · cited 1×
“The inhibition of -glucan synthesis by the echinocandins occurs predominantly through inhibition of Fks [ (1,3)-glucan synthase] subunits (1, 2).”
BackgroundPfaller, M. A., Diekema, D. J., Andes, D., Arendrup, M. C., Brown, S. D., Lockhart, S. R., Motyl, M., & Perlin, D. S. (2011) · Drug Resistance Updates · doi:10.1016/j.drup.2011.01.004 · Cited by 334
Garcia-Effron, G., Katiyar, S. K., Park, S., Edlind, T. D., & Perlin, D. S. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00262-08 · Cited by 323 · cited 2×
“parapsilosis is thought to be intrinsically less susceptible to CSF due to an alanine occurring naturally at position 660 in Fks1, which replaces the proline found in other species (24).”
BackgroundGarcia-Effron, G., Lee, S., Park, S., Cleary, J. D., & Perlin, D. S. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00443-09 · Cited by 323 · cited 1×
“glabrata, resistance-conferring point mutations have also been identified in FKS2 that result in amino acid substitutions at positions 659 to 666 and 1375 (23).”
BackgroundFungal ß(1,3)-D-glucan synthesis
Douglas, C. M. (2001) · Medical Mycology · doi:10.1080/mmy.39.1.55.66 · Cited by 312
In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872)
Bartizal, K., Gill, C. J., Abruzzo, G. K., Flattery, A. M., Kong, L., Scott, P. M., Smith, J. G., Leighton, C. E., Bouffard, A., Dropinski, J. F., et al. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.11.2326 · Cited by 311
Munro, C. A., Selvaggini, S., De Bruijn, I., Walker, L., Lenardon, M. D., Gerssen, B., Milne, S., Brown, A. J. P., & Gow, N. A. R. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.05588.x · Cited by 309 · cited 2×
“The compensatory increase in chitin content in response to CSF treatment is mediated by the Ca(2) -calcineurin, protein kinase C (PKC), and HOG signaling pathways (7, 39).”
BackgroundSelf-citationCurrent Perspectives on Echinocandin Class Drugs
Perlin, D. S. (2011) · Future Microbiology · doi:10.2217/fmb.11.19 · Cited by 274 · cited 3×
“Isolates of different Candida species that are resistant to echinocandins, either in vitro or in vivo, have frequently acquired point mutations in the FKS1 or FKS2 target gene (7, 19, 20, 52).”
BackgroundFungal echinocandin resistance
Walker, L. A., Gow, N. A. R., & Munro, C. A. (2010) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2009.09.003 · Cited by 267
Self-citationMicafungin: A New Echinocandin
Chandrasekar, P. H., & Sobel, J. D. (2006) · Clinical Infectious Diseases · doi:10.1086/501020 · Cited by 256
Pfaller, M. A., Moet, G. J., Messer, S. A., Jones, R. N., & Castanheira, M. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01079-10 · Cited by 238
Plaine, A., Walker, L., Da Costa, G., Mora-Montes, H. M., McKinnon, A., Gow, N. A. R., Gaillardin, C., Munro, C. A., & Richard, M. L. (2008) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2008.08.003 · Cited by 238 · cited 3×
“albicans, both in vitro and in vivo (7, 41, 42).”
BackgroundSelf-citationBalashov, S. V., Park, S., & Perlin, D. S. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01653-05 · Cited by 225 · cited 2×
“Isolates of different Candida species that are resistant to echinocandins, either in vitro or in vivo, have frequently acquired point mutations in the FKS1 or FKS2 target gene (7, 19, 20, 52).”
BackgroundLipopeptide inhibitors of fungal glucan synthase
Kurtz, M. B., & Douglas, C. M. (1997) · Medical Mycology · doi:10.1080/02681219780000961 · Cited by 216 · cited 5×
“The echinocandin antifungal drugs inhibit synthesis of the major fungal cell wall polysaccharide (1,3)-glucan.”
BackgroundInfluentialElevated Cell Wall Chitin in Candida albicans Confers Echinocandin Resistance In Vivo
Lee, K. K., MacCallum, D. M., Jacobsen, M. D., Walker, L. A., Odds, F. C., Gow, N. A. R., & Munro, C. A. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00683-11 · Cited by 209 · cited 2×
“albicans, both in vitro and in vivo (7, 41, 42).”
BackgroundSelf-citationBougnoux, M.-E., Morand, S., & d'Enfert, C. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.4.1290-1297.2002 · Cited by 200
Reviews Of Anti‐infective Agents: Anidulafungin: A Novel Echinocandin
Vazquez, J. A., & Sobel, J. D. (2006) · Clinical Infectious Diseases · doi:10.1086/505204 · Cited by 199 · cited 1×
“parapsilosis than in the other two species (50).”
Pfaller, M. A., Diekema, D. J., Mendez, M., Kibbler, C., Erzsebet, P., Chang, S.-C., Gibbs, D. L., Newell, V. A., & the Global Antifungal Surveillance Group (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00865-06 · Cited by 194
Stevens, D. A., Ichinomiya, M., Koshi, Y., & Horiuchi, H. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00563-06 · Cited by 193
Laverdière, M., Lalonde, R. G., Baril, J.-G., Sheppard, D. C., Park, S., & Perlin, D. S. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl022 · Cited by 192 · cited 1×
“albicans occurs at Ser(645), in the first hot spot region (21, 22).”
BackgroundKatiyar, S., Pfaller, M., & Edlind, T. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00349-06 · Cited by 189
Caspofungin: the first in a new class of antifungal agents
Kartsonis, N. A., NIELSEN, J. B. K., & Douglas, C. M. (2003) · Drug Resistance Updates · doi:10.1016/s1368-7646(03)00064-5 · Cited by 173
Chamilos, G., Lewis, R. E., Albert, N., & Kontoyiannis, D. P. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00095-07 · Cited by 171 · cited 2×
“glabrata, showed that the frequency of the paradoxical effect is echinocandin specific and also species related (30, 31).”
BackgroundResultThe yeast cell-wall salvage pathway
Popolo, L., Gualtieri, T., & Ragni, E. (2001) · Medical Mycology · doi:10.1080/mmy.39.1.111.121 · Cited by 142 · cited 2×
“tations in FKS1 and is therefore more likely due to activation of cell wall salvage mechanisms (7, 37, 38).”
BackgroundPhenotype switching affects biofilm formation by Candida parapsilosis
Laffey, S. F., & Butler, G. (2005) · Microbiology · doi:10.1099/mic.0.27739-0 · Cited by 129 · cited 1×
“Interestingly, one main difference between the two yeast colonial forms, termed “smooth” and “crater,” is that smooth-phase yeast cells have a significantly lower chitin content, with chitin only at the poles of the cells (51).”
BackgroundKatragkou, Α., Chatzimoschou, A., Simitsopoulou, M., Dalakiouridou, M., Diza-Mataftsi, E., Tsantali, C., & Roilides, E. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00856-07 · Cited by 121
Melo, A. S., Colombo, A. L., & Arthington-Skaggs, B. A. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00676-07 · Cited by 117
Studies of the paradoxical effect of caspofungin at high drug concentrations
Stevens, D. A., White, T. C., Perlin, D. S., & Selitrennikoff, C. P. (2005) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2004.10.006 · Cited by 113 · cited 1×
“tations in FKS1 and is therefore more likely due to activation of cell wall salvage mechanisms (7, 37, 38).”
BackgroundPfaller, M. A., Diekema, D. J., Gibbs, D. L., Newell, V. A., Ng, K. P., Colombo, A., Finquelievich, J., Barnes, R., & Wadula, J. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.02122-07 · Cited by 108
Effects of Caspofungin against Candida guilliermondii and Candida parapsilosis
Barchiesi, F., Spreghini, E., Tomassetti, S., Della Vittoria, A., Arzeni, D., Manso, E., & Scalise, G. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00111-06 · Cited by 98
Bizerra, F. C., Melo, A. S. A., Katchburian, E., Freymüller, E., Straus, A. H., Takahashi, H. K., & Colombo, A. L. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00633-10 · Cited by 91 · cited 2×
“glabrata, showed that the frequency of the paradoxical effect is echinocandin specific and also species related (30, 31).”
BackgroundSequence resources at the Candida Genome Database
Arnaud, M. B., Costanzo, M. C., Skrzypek, M. S., Shah, P., Binkley, G., Lane, C., Miyasato, S. R., & Sherlock, G. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkl899 · Cited by 73
FsFKS1, the 1,3-β-Glucan Synthase from the Caspofungin-Resistant Fungus Fusarium solani
Ha, Y.-S., Covert, S. F., & Momany, M. (2006) · Eukaryotic Cell · doi:10.1128/ec.00030-06 · Cited by 70 · cited 1×
“Similarly, other intrinsically less susceptible fungal species, such as Neurospora crassa, Fusarium solani, Fusarium graminearum, Fusarium verticillioides, and Magnaporthe grisea, contain a tyrosine at residue 641, replacing the phenylalanine found in Fks1 proteins of susceptible species (25, 26).”
BackgroundCota, J. M., Grabinski, J. L., Talbert, R. L., Burgess, D. S., Rogers, P. D., Edlind, T. D., & Wiederhold, N. P. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01542-07 · Cited by 69 · cited 2×
“The difference in results between this work and a previous study (48) may relate to strain differences in the C.”
ResultPfaller, M. A., Chaturvedi, V., Diekema, D. J., Ghannoum, M. A., Holliday, N. M., Killian, S. B., Knapp, C. C., Messer, S. A., Miskov, A., & Ramani, R. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00493-08 · Cited by 68 · cited 1×
“parapsilosis isolates tested were significantly less susceptible to CSF than most other Candida species (Table 2) (14).”
BackgroundShields, R. K., Nguyen, M. H., Du, C., Press, E., Cheng, S., & Clancy, C. J. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00999-10 · Cited by 65 · cited 2×
“The paradoxical effect has been debated as being only an in vitro phenomenon because it apparently does not occur in the presence of human serum (36).”
BackgroundMiranda-Zapico, I., Eraso, E., Hernandez-Almaraz, J. L., Lopez-Soria, L. M., Carrillo-Munoz, A. J., Hernandez-Molina, J. M., & Quindos, G. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr298 · Cited by 65
Pfaller, M. A., Castanheira, M., Diekema, D. J., Messer, S. A., & Jones, R. N. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.05047-11 · Cited by 62
Paradoxical echinocandin activity: a limited in vitro phenomenon?
Wiederhold, N. P. (2009) · Medical Mycology · doi:10.1080/13693780802428542 · Cited by 48
Killing Kinetics of Caspofungin, Micafungin, and Amphotericin B against Candida guilliermondii
Cantón, E., Pemán, J., Sastre, M., Romero, M., & Espinel-Ingroff, A. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00524-06 · Cited by 37
Echinocandins: Addressing outstanding questions surrounding treatment of invasive fungal infections
Holt, S. L., & Drew, R. H. (2011) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp100456 · Cited by 26
Pai, M. P., Jones, A. L., & Mullen, C. K. (2007) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2006.10.017 · Cited by 12
Physiological and morphological characteristics of yeasts isolated from waste oil effluents
Romero, M. C., Gatti, M. E., Córdoba, S. B., Cazau, M. C., & Arambarri, A. M. (2000) · World Journal of Microbiology and Biotechnology · doi:10.1023/a:1008935706559 · Cited by 9 · cited 2×
“Isolates taken from the most polluted areas had the highest chitin contents, whereas isolates with low chitin levels were predominant in areas with less pollution (54).”
BackgroundCantón, E., Pemán, J., Romero, M., Valentín, A., & Gobernado, M. (2007) · PubMed · Cited by 6
DNA Sequencing by Chemical Degradation Using One, Two, and Four Different Fluorophores
Rosenthal, A. (2003) · Humana Press eBooks · doi:10.1385/0-89603-248-5:261 · Cited by 4
Cantón, R., Pemán, J., Romero, M., et al. (2007) · PubMed · Cited by 3
Pfaller, M. A., Hollis, R. J., Goldstein, B. P., Messer, S. A., Diekema, D. J., & Henkel, T. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.00806-10 · Cited by 3
Cited by
The Fungal Cell Wall: Candida, Cryptococcus, and Aspergillus Species
Garcia-Rubio, R., de Oliveira, H. C., Rivera, J., & Trevijano-Contador, N. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02993 · Cited by 917
Antifungal Drug Resistance: Molecular Mechanisms in Candida albicans and Beyond
Lee, Y., Puumala, E., Robbins, N., & Cowen, L. E. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00199 · Cited by 801
Mechanisms of Antifungal Drug Resistance
Cowen, L. E., Sanglard, D., Howard, S. J., Rogers, P. D., & Perlin, D. S. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019752 · Cited by 647
“2008), and constitutive up-regulation of chitin is associated with echinocandin resistance caused by FKS1 mutations (Walker et al. 2013).”
BackgroundInfluentialDrug resistance and tolerance in fungi.
Berman, J., & Krysan, D. J. (2020) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0322-2 · Cited by 642
Candida sp. Infections in Patients with Diabetes Mellitus
Rodrigues, C., Rodrigues, M., & Henriques, M. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8010076 · Cited by 315
Metadata
- Authors
- Walker, L. A., Gow, N. A. R., & Munro, C. A.
- Affiliations
- University of Aberdeen (GB)
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2013-01
- Volume
- 57
- Issue
- 1
- Pages
- 146-154
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC3535899
- OpenAlex
- W1995932180
- Cited by
- 214
- References
- 55
- Citations by year
- 2026: 18 · 2025: 14 · 2024: 22 · 2023: 13 · 2022: 14 · 2021: 17 · 2020: 19 · 2019: 18 · 2018: 15 · 2017: 19 · 2016: 10 · 2015: 10 · 2014: 13 · 2013: 12
- FWCI
- 7.99
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Aberdeen University Research Archive (Aberdeen University) (submittedVersion)
- Funders
- Gilead Sciences
- Wellcome Trust (086827, 080088, 075470)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Fungal Plant Pathogen Control
- Keywords
- chitin synthesis, caspofungin, echinocandin resistance, Candida, Candida albicans, Candida parapsilosis, Candida guilliermondii, Candida tropicalis, Candida krusei, Candida glabrata, FKS1, β-1,3-glucan, calcineurin signaling, protein kinase C signaling, antifungal drug tolerance, fungal cell wall
- MeSH terms
- Caspofungin, Amino Acid Sequence, Antifungal Agents, Candida, Candidiasis, Cell Wall, Chitin, Fungal Proteins, Glucosyltransferases, Humans, Molecular Sequence Data, Protein Kinase C, Species Specificity, Signal Transduction, Gene Expression Regulation, Fungal, Sequence Alignment, Calcineurin, Drug Resistance, Fungal, Echinocandins, Lipopeptides
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.